Objectives: We studied the effect of local approval of syringe exchange programs in California (through Assembly AB136) on program availability and performance.
Methods: We determined the number of active syringe exchange programs in California by conducting Internet searches and obtaining information from the state and from local programs. To track changes in program availability and performance between 2000 and 2002, we interviewed 24 program directors annually for 3 years about program characteristics, syringe exchange policies, law enforcement contact, and other issues. We conducted multivariate analyses to determine whether AB136 approval status was associated with changes in performance.
Results: Fifteen local governments (13 counties and 2 cities) enacted the new law by 2002, and operating syringe exchange programs increased from 24 to 35. The proportion of these programs that were not locally approved declined from 54% to 40%. No new approved programs were started in high-need counties. Total syringes exchanged increased by more than 1 million per year, average annual budgets increased by more than 50%, and police harassment of the program volunteers, clients, and operators declined. Improvements at approved syringe exchange programs accounted for these changes.
Conclusions: Statewide approval and funding appears necessary to further syringe exchange availability in California.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376876 | PMC |
http://dx.doi.org/10.2105/AJPH.2005.080770 | DOI Listing |
Clin Adv Periodontics
December 2024
Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Background: In soft tissue regeneration, the clinical efficacy of fibrin membranes has been a pressing concern. The key to this efficacy lies in the stability of membrane and its controlled absorption. Human serum albumin, with its influence on the formation and stability of fibrin networks, could hold the key to developing a more stable alternative.
View Article and Find Full Text PDFCureus
December 2024
Department of Nursing, Fujieda Municipal General Hospital, Fujieda, JPN.
Background: This study aimed to verify that the modified quick change (mQC) method of syringe exchange in critically ill patients receiving a continuous intravenous norepinephrine infusion is not inferior to the conventional double pumping (DP) method.
Methods: This non-blinded, quasi-randomized, non-inferiority trial was conducted in a single hospital from August 1, 2023 to February 29, 2024. Adult patients aged 18 years or older who were admitted to the emergency ward and received a continuous intravenous norepinephrine infusion were eligible for inclusion.
Open Forum Infect Dis
November 2024
Prevention Point Philadelphia, Philadelphia, Pennsylvania, USA.
Cabotegravir + rilpivirine (CAB + RPV-LA) is a long-acting antiretroviral therapy (ART) that can be utilized for people with human immunodeficiency virus (HIV) who face barriers to daily ART. Here, we describe the implementation of a program that provides low-barrier access to CAB + RPV-LA for people with HIV and opioid use disorder at a syringe exchange.
View Article and Find Full Text PDFJ Am Pharm Assoc (2003)
November 2024
UNC Eshelman School of Pharmacy, 201 Pharmacy Lane, CB 7355, Chapel Hill, NC, 27599-7355, USA.
Background: There's limited information available about the range of harm reduction (HR) services provided by rural pharmacies.
Objective: This study's objectives are to describe the types of HR services offered by rural pharmacies and examine pharmacists' attitudes and willingness to offer those services.
Methods: A cross-sectional online survey was sent to pharmacists who are members of a practice-based research network for rural community pharmacies.
Forensic Sci Int
December 2024
Laboratory of Toxicology, Research unit of Toxicology and Environment LR12SP07, Center Mahmoud Yaccoub for Urgent Medical Assistance, Tunis 1008, Tunisia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!